يعرض 1 - 10 نتائج من 60 نتيجة بحث عن '"F Saba"', وقت الاستعلام: 1.24s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Phase II Trial of CDX-3379 and Cetuximab in Recurrent/Metastatic, HPV-Negative, Cetuximab-Resistant Head and Neck Cancer

    المؤلفون: Julie E. Bauman, Ricklie Julian, Nabil F. Saba, Trisha M. Wise-Draper, Douglas R. Adkins, Paul O’Brien, Mary Jo Fidler, Michael K. Gibson, Umamaheswar Duvvuri, Margo Heath-Chiozzi, Diego Alvarado, Richard Gedrich, Philip Golden, Roger B. Cohen

    المصدر: Cancers; Volume 14; Issue 10; Pages: 2355

    مصطلحات موضوعية: head and neck cancer, EGFR, ErbB3, cetuximab, CDX-3379

    وصف الملف: application/pdf

    العلاقة: Cancer Therapy; https://dx.doi.org/10.3390/cancers14102355Test

    الإتاحة: https://doi.org/10.3390/cancers14102355Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study

    المؤلفون: Christine H. Chung, Marcelo Bonomi, Conor E. Steuer, Jiannong Li, Priyanka Bhateja, Matthew Johnson, Jude Masannat, Feifei Song, Juan C. Hernandez-Prera, Bruce M. Wenig, Helen Molina, Joaquim M. Farinhas, Caitlin P. McMullen, J. Trad Wadsworth, Krupal B. Patel, Julie A. Kish, Jameel Muzaffar, Kedar Kirtane, James W. Rocco, Michael J. Schell, Nabil F. Saba

    المصدر: Cancers; Volume 13; Issue 5; Pages: 1180

    مصطلحات موضوعية: cetuximab, nivolumab, pembrolizumab, real world data, HNSCC

    وصف الملف: application/pdf

    العلاقة: Clinical Trials of Cancer; https://dx.doi.org/10.3390/cancers13051180Test

    الإتاحة: https://doi.org/10.3390/cancers13051180Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use

    المؤلفون: Jeffery S. Russell, Shanmugasundaram Ramkumar, Everett E. Vokes, Robert L. Ferris, Makoto Tahara, Maura L. Gillison, Lisa Licitra, Mark Lynch, Robert I. Haddad, Joël Guigay, Caroline Even, Nabil F. Saba, Kevin J. Harrington, Fernando Concha-Benavente, Jérôme Fayette, Li Li, Peter Brossart, George R. Blumenschein, A. Dimitrios Colevas

    المصدر: Clin Cancer Res

    مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Cetuximab, Article, law.invention, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, medicine, Humans, Neoplasm Metastasis, Survival rate, Aged, Aged, 80 and over, Chemotherapy, Squamous Cell Carcinoma of Head and Neck, business.industry, Immunotherapy, Middle Aged, ErbB Receptors, Survival Rate, Clinical trial, Nivolumab, 030104 developmental biology, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a754089cc56f4bc972d5ecdf0accbd84Test
    https://doi.org/10.1158/1078-0432.ccr-18-3944Test


    أضف إلى المفضلة
  4. 4
    Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial

    المؤلفون: Brian A. Van Tine, Noha N. Salama, Conor E. Steuer, Juneko E. Grilley-Olson, Nabil F. Saba, Assuntina G. Sacco, Jessica Ley, Ronald J. Maggiore, Kevin Palka, Peter Oppelt, Francis P. Worden, Kathryn Trinkaus, Prakash Neupane, Douglas Adkins

    المصدر: The Lancet Oncology. 20:1295-1305

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Pyridines, Cetuximab, Palbociclib, Neutropenia, Disease-Free Survival, Piperazines, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, Cyclin D1, Papillomaviridae, neoplasms, Cyclin-Dependent Kinase Inhibitor p16, Aged, Platinum, EGFR inhibitors, Performance status, Squamous Cell Carcinoma of Head and Neck, business.industry, Head and neck cancer, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Drug Resistance, Neoplasm, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6e395a864abf4f528ebfc3a7fb530eTest
    https://doi.org/10.1016/s1470-2045Test(19)30405-x


    أضف إلى المفضلة
  5. 5
    Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age

    المؤلفون: Jérôme Fayette, Vijayvel Jayaprakash, Kevin J. Harrington, Robert L. Ferris, Li Li, Maura L. Gillison, Peter Brossart, Nabil F. Saba, Joël Guigay, Lisa Licitra, Naomi Kiyota, George R. Blumenschein

    المصدر: Oral oncology

    مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Article, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Age, Phase 3 clinical trial, Internal medicine, Post-hoc analysis, Clinical endpoint, Medicine, Humans, Neoplasm Metastasis, 030223 otorhinolaryngology, Aged, Chemotherapy, Cetuximab, business.industry, Squamous Cell Carcinoma of Head and Neck, Age Factors, Immunotherapy, Nivolumab, Docetaxel, 030220 oncology & carcinogenesis, Squamous cell carcinoma of the head and neck, Methotrexate, Female, Oral Surgery, business, Biomarkers, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b537b3095b6632e460dcf479d75d0b2Test
    https://hdl.handle.net/20.500.14094/90006305Test


    أضف إلى المفضلة
  6. 6
    T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

    المؤلفون: Xuefeng Wang, Jameel Muzaffar, Kedar Kirtane, Feifei Song, Matthew Johnson, Michael J Schell, Jiannong Li, Sean J Yoder, Jose R Conejo-Garcia, Jose A Guevara-Patino, Marcelo Bonomi, Priyanka Bhateja, James W Rocco, Conor E Steuer, Nabil F Saba, Christine H Chung

    المصدر: Journal for ImmunoTherapy of Cancer. 10:e004512

    مصطلحات موضوعية: Pharmacology, Cancer Research, Squamous Cell Carcinoma of Head and Neck, T-Lymphocytes, Papillomavirus Infections, Immunology, Receptors, Antigen, T-Cell, Cetuximab, Nivolumab, Oncology, Head and Neck Neoplasms, Leukocytes, Mononuclear, Humans, Molecular Medicine, Immunology and Allergy, Biomarkers

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c130f0c86688cb78d9d377bfbb1398Test
    https://doi.org/10.1136/jitc-2022-004512Test


    أضف إلى المفضلة
  7. 7
    Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck

    المؤلفون: Bhamini Patel, Nabil F. Saba

    المصدر: Cancers
    Cancers, Vol 13, Iss 3545, p 3545 (2021)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Pembrolizumab, Disease, Review, head and neck squamous cell carcinoma, 03 medical and health sciences, 0302 clinical medicine, pembrolizumab and monoclonal antibody in SCCHN, Internal medicine, EGFR monoclonal antibodies, medicine, Epidermal growth factor receptor, combination immunotherapy and EGFR in head and neck cancer, RC254-282, Epidermal Growth Factor and squamous cell carcinoma, Chemotherapy, biology, Cetuximab, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, EGFR inhibition in head and neck cancer, medicine.disease, Head and neck squamous-cell carcinoma, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Nivolumab, EGFR and chemotherapy in SCCHN, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8387353a2dbf5b53450dc8318403d20Test
    https://pubmed.ncbi.nlm.nih.gov/34298761Test


    أضف إلى المفضلة
  8. 8
    Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)

    المؤلفون: Christopher C. Griffith, Sreenivas Nannapaneni, Mark W. El-Deiry, Lihua Shu, Zhengjia Chen, Xu Wang, Youzhi Sun, Nabil F. Saba, Dong M. Shin, Mihir R. Patel, Dongsheng Wang, Zhuo Georgia Chen

    المصدر: Oral oncology. 122

    مصطلحات موضوعية: Cancer Research, Cetuximab, Quinolones, chemistry.chemical_compound, Mice, Cell Line, Tumor, medicine, Animals, Humans, neoplasms, EGFR inhibitors, Cell growth, business.industry, Squamous Cell Carcinoma of Head and Neck, Cancer, medicine.disease, Head and neck squamous-cell carcinoma, Xenograft Model Antitumor Assays, Oncology, chemistry, Apoptosis, Drug Resistance, Neoplasm, Head and Neck Neoplasms, Cancer research, Tipifarnib, Oral Surgery, Growth inhibition, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a39167362102b5ed83cdf90a8db9466Test
    https://pubmed.ncbi.nlm.nih.gov/34700281Test


    أضف إلى المفضلة
  9. 9
    Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab

    المؤلفون: Daniel J, Glazar, Matthew, Johnson, Joaquim, Farinhas, Conor E, Steuer, Nabil F, Saba, Marcelo, Bonomi, Christine H, Chung, Heiko, Enderling

    المصدر: Oral Oncology. 127:105787

    مصطلحات موضوعية: Cancer Research, Nivolumab, Oncology, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck, Antineoplastic Combined Chemotherapy Protocols, Cetuximab, Humans, Treatment Failure, Neoplasm Recurrence, Local, Oral Surgery

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9a90e32b2d032115cba4b03d223844Test
    https://doi.org/10.1016/j.oraloncology.2022.105787Test


    أضف إلى المفضلة
  10. 10
    De-escalation studies in HPV-positive oropharyngeal cancer: how should we proceed?

    المؤلفون: Antti Mäkitie, June Corry, Alvaro Sanabria, Boudewijn J.M. Braakhuis, Johannes A. Langendijk, Arlene A. Forastiere, Robert P. Takes, Ricard Simo, Yong Teng, Alfio Ferlito, Mateusz Szewczyk, Pasquale Di Maio, L.P. Kowalski, Nabil F. Saba, Andrés Coca-Pelaz, Remco de Bree, Vincent Vander Poorten, Elisabeth V. Sjögren, Paweł Golusiński, Juan P. Rodrigo, Stefan M. Willems

    المساهمون: HUS Head and Neck Center, Clinicum, Korva-, nenä- ja kurkkutautien klinikka, Research Program in Systems Oncology

    المصدر: WOS:000737279400010
    Oral Oncology, 123
    Oral Oncology, 123. ELSEVIER
    RUO. Repositorio Institucional de la Universidad de Oviedo
    instname

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, ADVANCED HEAD, 3122 Cancers, HPV-positive oropharyngeal cancer, Malignancy, law.invention, RISK HUMAN-PAPILLOMAVIRUS, 03 medical and health sciences, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, Randomized controlled trial, TRANSORAL ROBOTIC SURGERY, law, Internal medicine, RADIATION-THERAPY, medicine, CONCURRENT CHEMORADIOTHERAPY, Humans, Therapy efficacy, Head and neck, Papillomaviridae, Retrospective Studies, 030304 developmental biology, 0303 health sciences, business.industry, Incidence (epidemiology), Papillomavirus Infections, medicine.disease, 3126 Surgery, anesthesiology, intensive care, radiology, PHASE-III, CETUXIMAB, 313 Dentistry, 3. Good health, Oropharyngeal Neoplasms, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, SURVIVAL, Observational study, SQUAMOUS-CELL CARCINOMA, Oral Surgery, business, De-escalation, RADIOTHERAPY, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

    وصف الملف: application/pdf; Print-Electronic

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f4c2d0ad74a6ed1db05c06e86a4510Test
    http://hdl.handle.net/10651/64656Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث